MedPath

广州康臣药业有限公司

Ownership
-
Established
1997-12-29
Employees
-
Market Cap
-
Website
https://www.chinaconsun.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

NMPA:18

Drug Approvals

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20253093
Approval Date
Jan 8, 2025
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20249771
Approval Date
Dec 25, 2024
NMPA

Iopromide Injection

Product Name
碘普罗胺注射液
Approval Number
国药准字H20244584
Approval Date
Jul 30, 2024
NMPA

Iopromide Injection

Product Name
碘普罗胺注射液
Approval Number
国药准字H20244583
Approval Date
Jul 30, 2024
NMPA

Iodixanol Injection

Product Name
碘克沙醇注射液
Approval Number
国药准字H20244404
Approval Date
Jul 9, 2024
NMPA

Iopamidol Injection

Product Name
碘帕醇注射液
Approval Number
国药准字H20237170
Approval Date
May 14, 2024
NMPA

Iopamidol Injection

Product Name
碘帕醇注射液
Approval Number
国药准字H20193196
Approval Date
May 14, 2024
NMPA

Iopamidol Injection

Product Name
碘帕醇注射液
Approval Number
国药准字H20193195
Approval Date
May 14, 2024
NMPA

Iopamidol Injection

Product Name
碘帕醇注射液
Approval Number
国药准字H20237169
Approval Date
May 14, 2024
NMPA

益肾化湿颗粒

Approval Number
国药准字Z20090250
Approval Date
Jul 7, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.